You are here:
The Copenhagen Declaration developed by the Global Diabetes Forum outlines a new vision for combating the global type 2 diabetes epidemic. More than 50 experts from industrialized and emerging countries are calling for far-reaching changes in…
At this year’s Congress of the German Diabetes Association (DDG), three researchers from Helmholtz Munich were honored for their outstanding scientific achievements. Their groundbreaking work is helping to advance the understanding, prevention, and…
Researchers from the Institute of Diabetes Research and Metabolic Diseases of Helmholtz Munich at the Eberhard Karls University of Tübingen, the University Hospital of Tübingen, the German Center for Diabetes Research (DZD), as well as the…
Prof. Anette-Gabriele Ziegler, Director of the Helmholtz Munich Institute for Diabetes Research, is awarded with this year’s Hamm International Prize. She is being honored for her research to understand the pathogenesis of type 1 diabetes and efforts…
Helmholtz Munich has been awarded a prestigious grant from Breakthrough T1D, a leading global type 1 diabetes (T1D) research and advocacy organization, to enhance the effectiveness of stem cell-derived islet transplantation for T1D. By integrating…
Starting May 1, 2025, the pioneering study “Fr1da” for early detection of type 1 diabetes will expand into the German states of Hesse and Rhineland-Palatinate. Pediatric practices in these regions will then be able to offer families with children…
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:
